New funding supports advancement of avian metapneumovirus vaccine

This $250,000 investment in avian metapneumovirus vaccine development indicates potential future reductions in poultry mortality and improved flock health, which could lead to more stable and potentially higher supply volumes in the long term. Buyers should monitor the progress of this research, as successful vaccine deployment could influence future sourcing strategies by mitigating disease-related supply chain risks and potentially improving the overall cost-effectiveness of poultry protein.